Acasti Pharma OverviewAcasti Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ACST.
Quarterly EBIT
$0.00
As of Dec 31, 2025
Annual EBIT (TTM)
-$617.00K
↑ 96.58% YoY
Trailing 12 months ending Dec 31, 2025
Acasti Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for ACST.
As of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025